A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in Southwestern Ontario, Canada
References (17)
- et al.
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II—Therapy
Can J Cardiol
(2006) - et al.
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)
Int J Cardiol
(2006) - et al.
Prevalence and treatment of dyslipidemia in Canadian primary care: A retrospective cohort analysis
Clin Ther
(2007) - et al.
Can primary care doctors prescribe exercise to improve fitness? The Step Test Exercise Prescription (STEP) project
Am J Prev Med
(2003) - et al.
Multiple cardiovascular disease risk factors in Canadian adults
CMAJ
(1992) - et al.
Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: Summary of the 2003 update [published correction appears in CMAJ. 2003;169:1149].
CMAJ
(2003) - et al.
Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men
Arch Intern Med
(1992)
Cited by (23)
The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States
2013, Canadian Journal of CardiologyCitation Excerpt :However, our more important finding was that despite concerns that patients with multiple comorbidities may have their BP less well treated,8 we found that BP control rates actually improved as the number of other risk factors increased in both Canada and the United States. This pattern was also reported in medical record audits from a group of primary care practices in Southwestern Ontario in 200421 but has not been seen in other jurisdictions.22,23 Thus, while control rates for hypertension have improved markedly in both Canada12 and the United States24 during the past 2 decades, the persistently high prevalence of additional CV risk factors in hypertensive individuals will blunt the potential magnitude of the reductions in CV morbidity and mortality that would have been expected otherwise.
Treating Hypertension to Reduce Cardiovascular Risk: A Korean Perspective
2012, Clinical TherapeuticsCitation Excerpt :Furthermore, strategies to improve hypertension treatment may be effective in reducing the global risk of cardiovascular events not only by improving blood pressure control but also by improving the control of other risk factors such as diabetes mellitus and hypercholesterolemia. Hypertension usually clusters with other cardiovascular risk factors, such as insulin resistance, visceral obesity, and dyslipidemia.16 The clustering of cardiovascular risk factors greatly increases an individual's risk for cardiovascular morbidity and mortality.17
The Impact of Dietary Changes and Dietary Supplements on Lipid Profile
2011, Canadian Journal of CardiologyChanges in the rates of awareness, treatment and control of hypertension in Canada over the past two decades
2011, CMAJ. Canadian Medical Association JournalCitation Excerpt :This is encouraging, as it suggests that either Canadian physicians appropriately target more intensive therapy to patients at higher risk or that patients at higher risk are more compliant with their therapy. A similar result was seen in a chart audit of more than 10 000 patients from primary care practices in southwestern Ontario,24 but such a result has not been seen in other countries.25–27 This is important, as targeting therapy toward people with established disease or multiple cardiovascular risk factors will lead to greater absolute benefits than treatment strategies targeting only single risk factors.28
High cardiovascular risk and poor adherence to guidelines in 11 069 patients of middle age and older in primary care centres
2010, European Journal of Preventive Cardiology